Article

Urotensin II stimulates plasma extravasation in mice via UT receptor activation.

Department of Experimental and Clinical Medicine, Section of Pharmacology, University of Ferrara, via Fossato di Mortara 19, 44100 Ferrara, Italy.
Archiv für Experimentelle Pathologie und Pharmakologie (impact factor: 2.65). 12/2004; 370(5):347-52. DOI:10.1007/s00210-004-0991-9 pp.347-52
Source: PubMed

ABSTRACT The peptide urotensin II (U-II) is the cognate ligand of the G-protein coupled receptor UT (formerly GPR14). A role in the regulation of cardiovascular functions has been proposed for this novel peptide/receptor system. In the present study, we evaluated the ability of U-II to induce plasma extravasation in mice and attempted to characterize the receptor involved using the novel UT receptor ligand, [Orn(8)]U-II. The Evans blue technique was used to quantify plasma extravasation. U-II (0.01, 0.1, 1 and 10 nmol/kg) dose-dependently stimulated plasma extravasation in airways, gastrointestinal and urogenital tract tissues from mice, but not in the skin. In most tissues, the dose/response curves to U-II were bell shaped with the maximal effect induced by 1 nmol/kg. [Orn(8)]U-II at 30 nmol/kg was per se either inactive or produced a non-significant increase in plasma extravasation; in the presence of 30 nmol/kg [Orn(8)]U-II, the effects of 1 nmol/kg U-II were always reduced and, in some tissues, abolished. The present findings demonstrate that U-II promotes plasma extravasation in various mouse vascular regions via activation of UT receptors. The mouse plasma extravasation assay will be a useful tool in future studies aimed at characterizing the pharmacological features of novel UT receptor ligands in vivo.

0 0
 · 
0 Bookmarks
 · 
15 Views

Keywords

1 nmol/kg
 
1 nmol/kg U-II
 
cognate ligand
 
dose/response curves
 
Evans blue technique
 
future studies
 
induce plasma extravasation
 
mouse plasma extravasation assay
 
non-significant increase
 
novel peptide/receptor system
 
novel UT receptor ligand
 
novel UT receptor ligands
 
peptide urotensin II
 
pharmacological features
 
present findings
 
U-II promotes plasma extravasation
 
urogenital tract tissues
 
useful tool
 
UT receptors
 
various mouse vascular regions